Insider · CIK 0001293923

Holmes W Stephen

CIK 0001293923 Name as filed on the most recent filing

Filed as Holmes W Stephen (19)

37 transaction lines · from 19 filings · filed 2004-06-23 to 2015-04-14 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2015-04-14 P, Open-market purchase Carbylan Therapeutics, Inc.CBYL 4,050,000, acquired Open Form 4 filing 0001209191-15-034055
2014-05-30 S, Open-market sale Marketo, Inc.MKTO 3 lines 857,531, disposed Open Form 4 filing 0001209191-14-038353
2014-05-29 S, Open-market sale Marketo, Inc.MKTO 5 lines 2,149,245, disposed Open Form 4 filing 0001209191-14-038353
2014-05-21 S, Open-market sale Marketo, Inc.MKTO 120,000, disposed Open Form 4 filing 0001209191-14-036162
2014-05-20 S, Open-market sale Marketo, Inc.MKTO 120,090, disposed Open Form 4 filing 0001209191-14-036162
2014-05-16 S, Open-market sale Marketo, Inc.MKTO 344,427, disposed Open Form 4 filing 0001209191-14-035506
2014-05-14 S, Open-market sale Marketo, Inc.MKTO 206,006, disposed Open Form 4 filing 0001209191-14-034199
2014-05-13 S, Open-market sale Marketo, Inc.MKTO 2 lines 630,421, disposed Open Form 4 filing 0001209191-14-034199
2014-04-01 P, Open-market purchase Applied Genetic Technologies CorpAGTC 904,512, acquired Open Form 4 filing 0001209191-14-024062
2014-02-28 S, Open-market sale Marketo, Inc.MKTO 207,800, disposed Open Form 4 filing 0001209191-14-015493
2014-02-27 S, Open-market sale Marketo, Inc.MKTO 816,805, disposed Open Form 4 filing 0001209191-14-015493
2014-02-26 S, Open-market sale Marketo, Inc.MKTO 2 lines 1,334,792, disposed Open Form 4 filing 0001209191-14-015281
2014-02-13 S, Open-market sale Marketo, Inc.MKTO 177,045, disposed Open Form 4 filing 0001209191-14-011259
2013-09-18 S, Open-market sale Marketo, Inc.MKTO 70,818,664, disposed Open Form 4 filing 0001104659-13-070841
2012-07-03 P, Open-market purchase Tesaro, Inc.TSRO 5,999,994, acquired Open Form 4 filing 0001209191-12-037464
2011-09-21 P, Open-market purchase Transcept Pharmaceuticals IncTSPT 1,573,122, acquired Open Form 4 filing 0001209191-11-048898
2011-02-07 S, Open-market sale Epocrates IncEPOC 2 lines 6,819,568, disposed Open Form 4 filing 0001104659-11-005370
2010-08-06 P, Open-market purchase Trius Therapeutics IncTSRX 6,136,665, acquired Open Form 4 filing 0001181431-10-041126
2008-04-16 P, Open-market purchase Metabasis Therapeutics IncMBRX 2 lines 2,318,509, acquired Open Form 4 filing 0001209191-08-024799
2007-12-18 P, Open-market purchase Anesiva, Inc.ANSV 3 lines 8,000,001, acquired Open Form 4 filing 0001209191-07-071119
2007-11-15 P, Open-market purchase EnteroMedics IncETRM 1,500,000, acquired Open Form 4 filing 0001209191-07-065051
2005-09-30 P, Open-market purchase Metabasis Therapeutics IncMBRX 2 lines 2,499,999, acquired Open Form 4 filing 0001209191-05-050703
2004-06-21 P, Open-market purchase Metabasis Therapeutics IncMBRX 2 lines 910,000, acquired Open Form 4 filing 0001179044-04-000257

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Holmes W Stephen, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001293923

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.